Cover Image

DEHYDROEPIANDROSTERONE LEVELS IN TYPE 2 DIABETES

RATHNAKUMARI .

Abstract


BACKGROUND Dehydroepiandrosterone (DHEA) is a steroid hormone secreted by the adrenal cortex. Recent          research reports show that DHEA has various beneficial effects including enhancing insulin sensitivity. This is still under study and yet to be proved in humans.AIM To estimate the levels of DHEA and HbA1c in men with Type 2 diabetes, in comparison with normal subjects of the same age group.MATERIALS AND METHODS A cross sectional comparative study of sixty               participants (60 to 70 years of age), thirty men with                 uncomplicated Type 2 diabetes for at least five years duration and thirty non-diabetic controls was done. Informed consent was obtained. Serum levels of DHEA were estimated for all the participants by ELISA method. Their glycemic status was           determined by HbA1c levels. Statistical analysis was done using unpaired T-test. Significance level was fixed at p value less than 0.05. RESULTS A significant decrease in the DHEA level was observed in Type 2 diabetes individuals compared with normal subjects. Significant increase in the HbA1C level was observed in diabetic individuals compared to normal. CONCLUSION In cases with type 2 diabetes significantly lower levels of Serum DHEA was associated with significantly poorer glycemic control in comparison with normal subjects.


Full Text:

PDF

References


Adams JB Control of secretion and function of C19-delta 5-steroids of the human adrenal gland. Mol Cell Endocrinol 1985; 41:1–17.

Lamberts SWJ, van den Beld AW, van der Lely A-J: The endocrinology of aging. Science 278:419–424, 1997.

Kern PA, Saghizadeh M, Ong LM, Bosch RJ, Deem R, Simsolo RB 1995 the expression of tumor necrosis factor in human adipose tissue: regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95:2111–2119.

Ionescu E, Sauter JF, Jeanrenaud B 1985 Abnormal glucose tolerance in genetically obese (fa/fa) rats. Am J Physiol 248: E500–E506

Kasiske BL, O’Donnell MP, Keane WF 1992 The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury. Hypertension 19:I110 –I115

Cleary MP, Zabel T, Sartin JL 1988 Effects of short-term

dehydroepiandrosterone treatment on serum and pancreatic insulin in Zucker rats. J Nutr 118:382–387.

Coleman DL, Leiter EH, Schwizer RW: Therapeutic effects of

dehydroepiandrosterone (DHEA) in diabetic mice. Diabetes 31:830–833, 1982

Coleman DL, Schwizer RW, Leiter EH: Effect of genetic background on the therapeutic effects of dehydroepiandrosterone (DHEA) in diabetes-obesity mutants and in aged normal mice. Diabetes 33:26–32, 1984

Coleman DL, Leiter EH, Applezweig N: Therapeutic effects of dehydroepiandrosterone metabolites in diabetes mutant mice (C57BL/KsJ-db/db). Endocrinology 115:239–243, 1984

Hansen PA, Han DH, Nolte LA, Chen M, Holloszy JO: DHEA protects against visceral obesity and muscle insulin resistance in rats fed a high-fat diet. Am J Physiol 273:R1704–R1708, 1997

Cleary MP 1990 Effect of dehydroepiandrosterone treatment on liver metabolism in rats. Int J Biochem 22:205–210

Melby JC 1970 Assessment of adrenocortical function. N Engl J Med 285:735–739

Coleman DL, Leiter EH, Schwizer RW. Therapeutic effects of

dehydroepiandrosterone (DHEA) in diabetic mice. Diabetes 1982; 31: 830-833.

Karbowska J, Kochan Z. Effect of DHEA on endocrine function of adipose tissue, the involvement of PPAR. Biochem Pharmacol 2005; 70: 249-257.

Kajita K, Ishizuka T, Miura A, Ishizawa M, Kanoh Y, Yasuda K: The role of atypical and conventional PKC in dehydroepian drosterone-induced glucose uptake and dexamethasone-induced insulin resistance. Biochem Biophys Res Commun 277:361–367, 2000

Ishizuka T, Kajita K, Miura A, Ishizawa M, Kanoh Y, Itaya S, Kimura M, Muto N, Mune T, Morita H, Yasuda K: DHEA improves glucose uptake via activations of protein kinase C and phosphatidylinositol 3-kinase. Am J Physiol 276:E196–E204

Sebastio Perrini, Annalisa Natalicchio, Dehydro epiandrosterone Stimulates Glucose Uptake in Human and Murine Adipocytes by Inducing GLUT1 and GLUT4

Translocation to the Plasma Membrane diabetes, vol. 53, january 2004

Eldon D. Schriock, Cynthia K. Buffington, James R. Givens and John E. Buster Enhanced Post-Receptor Insulin Effects in Women Following Dehydroepiandrosterone Infusion, Journal of the Society for Gynecologic Investigation 1994 1: 74.

Villareal DT, Holloszy JO. Effect of DHEA on abdominal fat and insulin action in elderly women and men. JAMA 2004; 292: 2243-2248.

Kimura M, Tanaka S, Yamada Y, Kiuchi Y, Yamakawa T, Sekihara H. Dehydroepiandrosterone decreases serum tumor necrosis factor-alpha and restores insulin sensitivity: independent effect from secondary weight reduction in genetically obese Zucker fatty rats. Endocrinology 1998; 139: 3249-3253.

Usiskin KS, Butterworth S, Clore JN, et al. Lack of effect of dehydroepiandrosterone in obese men. Int J Obes 1990; 14: 457-463.

Nestler JE, Barlascini CO, Clore JN, Blackard WG. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab 1988; 66: 57-61.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr M.G.R. Medical University